Samsung Biologics Fined
- All
- News
'Samsung Biologics Fined' - 1 News Result(s)
-
Samsung Pharmaceutical Arm Fined For $4 Billion Accounts Breach
The pharmaceutical arm of giant South Korean conglomerate Samsung was fined Wednesday for alleged accounting breaches amounting to nearly $4 billion, and had dealings in its shares suspended indefinitely.
'Samsung Biologics Fined' - 1 News Result(s)
-
Samsung Pharmaceutical Arm Fined For $4 Billion Accounts Breach
The pharmaceutical arm of giant South Korean conglomerate Samsung was fined Wednesday for alleged accounting breaches amounting to nearly $4 billion, and had dealings in its shares suspended indefinitely.
